Conference Fees
- $90 – Providers/Advanced Practice Providers
- $45 – Nurses/Administrators/Other Health Care Professionals
- No Cost - Fellows/Residents/Students
Guthrie Providers: This conference is eligible for reimbursement from your 2027 allocated CME/Meeting fund.
Cancellation and Refund
The full conference fee is refundable, less $10 processing fee, if your cancellation is received, in writing by Friday, January 15, 2027. (The processing fee is nonrefundable regardless of the reason for cancellation). Refunds will not be granted after this time for non-attendance.
The Guthrie Clinic Office of CME reserves the right to cancel an activity due to unforeseen circumstances (i.e., lack of registrations, unexpected events). Any registrants will be notified, and refunds will be processed. In the event the activity has been postponed, the registrant will have the option to receive a full refund, or they can use their registration for the respective conference. In addition, The Guthrie Clinic Office of CME is not responsible for related costs or expenses to participants, including cancellation fees assessed by hotels, airlines, or travel agencies.
Disclaimers
Minimum and maximum numbers for attendance at this event have been established and we reserve the right to substitute speakers/topics or cancel if necessary. By attending this event, you grant The Guthrie Clinic Office of CME the right to record, film, photograph, or capture your likeness in any media and to distribute, broadcast, use, or otherwise disseminate, in perpetuity, such media without any further approval from or any payment to you.
The Guthrie Clinic CME Vision
"To empower health professionals with the resources and expertise to deliver exceptional preventive and comprehensive care, optimizing health outcomes for the communities we serve."
Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”
Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (7.5) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”
Faculty Disclosure
The Guthrie Clinic adheres to the ACCME® Standards for Integrity and Independence in Accredited Continuing Education.
“Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).” The presenting faculty/planning committee for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
A special Thank You to the Donald Guthrie Foundation for providing funding towards this symposium.
Saturday, February 6, 2027
Time: 8:00 a.m. to 5:00 p.m.
Location: Tioga Downs Casino Resort, 2384 W. River Rd., Nichols, N.Y.
THERE ARE A LIMITED NUMBER OF SEATS FOR THIS EVENT. PLEASE REGISTER EARLY TO SECURE!
Conference Description
Healthcare professionals caring for patients with cardiovascular disease must stay current with evolving guidelines, diagnostic strategies and treatment options to make informed clinical decisions. This conference will provide practical, evidence-based updates to help participants assess cardiovascular risk, select appropriate diagnostic testing, individualize treatment plans and recognize when referral for specialized cardiovascular care is warranted. Topics will include ASCVD prevention, coronary imaging, heart failure, cardiorenal-metabolic disease, atrial fibrillation, valvular heart disease and advances in interventional and surgical management. Through expert presentations and interactive debates, participants will explore emerging therapies, evaluate treatment options and strengthen collaboration across specialties to improve patient care and cardiovascular outcomes.
Intended Audience
This conference is designed to provide an evidence-based update on the evolving diagnosis, risk assessment and management of cardiovascular disease, with an emphasis on translating emerging guidelines, innovative therapies and advances in interventional cardiology into clinical practice. Participants will explore current approaches to ASCVD risk reduction, heart failure, cardiorenal-metabolic disease, atrial fibrillation, valvular heart disease and complex cardiovascular conditions. Emphasis will be placed on optimizing treatment decisions, individualizing patient care, improving recognition of cardiovascular disease in women, strengthening collaboration across specialties and identifying when advanced diagnostic testing, specialist consultation or referral for interventional or surgical management is appropriate.
The program is intended for primary care providers, cardiologists and other medical specialists, as well as advanced practice providers, registered nurses, cardiovascular fellows, residents, medical and nursing students and other allied healthcare professionals involved in the care of patients with cardiovascular disease.
Conference Goals
❤️Advance Cardiovascular Knowledge
Strengthen participants’ knowledge of current evidence, evolving guidelines, diagnostic strategies and emerging therapies for cardiovascular disease.
🩺Enhance Clinical Decision-Making
Equip participants to apply evidence-based approaches to individualized treatment, select appropriate diagnostic testing and recognize when specialized cardiovascular referral is warranted.
🤝Improve Collaborative Patient Care
Promote multidisciplinary collaboration and coordinated management of complex cardiovascular conditions to optimize treatment decisions and improve patient outcomes.
Elements of Competence
The CME activity has been designed to change learner competence and focus on the American Board of Medical Specialties areas of patient care, medical knowledge, practice-based learning and improvement, interpersonal and communication skills, professionalism and systems-based practice.
Educational Methods
- Live lectures with Q & A sessions will facilitate the dissemination of information.
- Interactive discussions are included to provider greater in-depth understanding of selected clinical issues.
Conference Objectives
At the conclusion of this activity, participants should be able to:
- Apply current evidence-based guidelines to assess atherosclerotic cardiovascular disease (ASCVD) risk, incorporate lipoprotein(a) testing into risk stratification, and select appropriate diagnostic strategies for evaluating suspected coronary artery disease.
- Recognize differences in cardiovascular disease presentation and outcomes among women and identify strategies to improve timely diagnosis, risk assessment and equitable evidence-based treatment.
- Evaluate individualized treatment approaches for heart failure with preserved ejection fraction (HFpEF) and cardiorenal-metabolic (CKM) syndrome by integrating clinical phenotyping, comorbidities and evidence-based therapeutic options.
- Develop coordinated management strategies for patients with complex cardiovascular conditions, including heart failure, atrial fibrillation, valvular heart disease and overlapping renal and metabolic disorders, through effective interprofessional collaboration.
- Identify appropriate candidates for advanced cardiovascular interventions by applying current evidence and referral criteria for pulsed field ablation, left atrial appendage occlusion (LAAO), transcatheter aortic valve replacement (TAVR), transcatheter edge-to-edge repair (TEER) and complex aortic procedures.
- Differentiate patients who may benefit from transcatheter interventions versus surgical management by evaluating clinical indications, procedural risks, disease complexity and the role of multidisciplinary heart team decision-making.
- Critically evaluate emerging cardiovascular therapies and evolving clinical evidence to support individualized treatment decisions regarding GLP-1 receptor agonists for patients with ASCVD and obesity and myosin inhibitors for hypertrophic cardiomyopathy (HCM).
Conference Agenda
- 8 a.m. - Welcome and Opening Remarks - Dr. Daniel Sporn
- 8:05 a.m. - ASCVD Risk in 2027: New Guidelines and the Rise of Lp(a) are Reshaping the Risk Conversation — Is your Practice Keeping Pace? - Dr. Saurabh Sharma
- 8:35 a.m. - CT First, Ask Questions Later? Rethinking the Stress Test: Coronary CT is Moving to the Front of the Line — Find Out Who Still Needs to Walk the Treadmill - Dr. Umut Gomceli
- 9:05 a.m. – GUEST SPEAKER - The Gender Gap in Heart Disease: What We're Still Missing: Women Present Differently, get Diagnosed Later, and are Treated Less Aggressively — Here's How to Close the Gap – Dr. Cynthia Taub
- 10 a.m. - Break
- 10:15 a.m. - HFpEF Unmasked: Matching Phenotype to Therapy: Not all HFpEF is the Same Disease — Precision Phenotyping is Changing How (and whether) We Treat It - Dr. Resha Khanal
- 10:45 a.m. - One Patient, Three Organs: The CKM Playbook: Heart, Kidney, and Metabolic Disease Share More than Risk Factors — They Share a Treatment Strategy - Dr. Bikal Lamichhane
- 11:15 a.m. – GUEST SPEAKER - Who's Driving? Navigating the Co-Managed HF Patient: When Cardiology, Primary Care, and Nephrology All Have a Stake, Who Actually Owns the Plan? - Dr. Hari Dandapantula
- 12 p.m. - Lunch / Exhibits
- 1 p.m. - AFib's New Arsenal: PFA, Early Rhythm Control & LAAO: Pulsed Field Ablation and Earlier Intervention are Rewriting the AFib Playbook - Dr. Ahmad Lone
- 1:35p.m. - When to Pull the TAVR Trigger: Indications Keep Expanding — A Practical Guide to Knowing Who to Refer, and When - Dr. Hammad Rahman
- 2:10 p.m. - Fixing the Leak: TEER for Mitral and Tricuspid Disease: Transcatheter Repair is No Longer Just for Mitral — Here's Where Tricuspid Fits In - Dr. Sudhakar Sattur
- 2:45p.m. – Break
- 3 p.m. - Advancing Complex Aortic Care: One – Year Experience with TAMBE - Dr. Amber Hussain
- 3:35 p.m. – GUEST SPEAKER - Still a Surgical Case? Drawing the Line with CTS: As Transcatheter Options Expand, What Still Absolutely Belongs in the OR? – Dr. Callistus Ditah
- DEBATES
4:15 p.m. - GLP-1 for All? The ASCVD-Obesity Showdown: Should Every ASCVD Patient with Obesity be on a GLP-1? - Two Speakers Make Their Case.
Dr. Shahmeer Lodhi and Dr. Hitesh Bhatia - 4:35p.m. - First-Line or Not Ready? The Myosin Inhibitor Debate: Myosin Inhibitors are Reshaping HCM Management - But are they Ready for First-Line Status?
Dr. Shiavax Rao and Dr. Prima Wulandari - 5p.m. - Closing Remarks and Adjournment - Dr. Syed Hamza Waheed
Conference Directors

Sudhakar Sattur, MD, MHSA
Chief, Section of Cardiology; Associate Program Director, Cardiovascular Fellowship
Robert Packer Hospital and Guthrie Medical Group, P.C., Sayre, PA

Najeeb Rehman, MD, MHA, FACC, FASE, FASNC
Director, Non-Invasive Cardiology, Guthrie Medical Group, P.C., Sayre, PA

Guy Rogers, Jr., MPAS, PA-C, DMSc
Advanced Practice Provider, Cardiology
Guthrie Medical Group, P.C., Sayre, PA

Syed Hamza Waheed, MD
Associate, Non-Invasive Cardiology
Guthrie Binghamton Cardiology, Binghamton, NY
Conference Guest Speakers

Hari Dandapantula, MD, FACC
Dr. Hari Dandapantula is a specialist in preventive cardiology at HCA Florida Healthcare in Largo Florida with 25 years of extensive experience in diagnosing and managing complex cardiovascular diseases. His practice is anchored in a deep understanding of cardiac physiology and pathology, with a particular focus on heart failure and arrhythmias. He leverages advanced diagnostic tools and evidence-based strategies to provide high-resolution clinical assessments and interventions. Dr. Dandapantula's approach prioritizes precise identification of disease mechanisms and optimization of cardiovascular function.
Callistus Ditah, MD
Dr. Callistus Ditah is an Assistant Professor of Surgery at SUNY Upstate Medical University in Syracuse, New York, specializing in cardiothoracic and aortic surgery. His clinical expertise includes coronary artery bypass grafting, mitral valve repair and replacement, aortic root surgery, and complex aortic disease. He has a particular interest in treating patients with connective tissue disorders, including Marfan syndrome, Ehlers-Danlos syndrome, and Loeys-Dietz syndrome. Dr. Ditah completed his medical degree at the University of Michigan Medical School and pursued advanced fellowship training in cardiothoracic and aortic surgery at the University of Washington. His research has been published in peer-reviewed medical journals, reflecting his commitment to advancing surgical care and improving patient outcomes.
Cynthia Taub, MD, MBA, FASE
Dr. Taub is the Edward C. Reifenstein Chair and Professor of Medicine at SUNY Upstate Medical University. An internationally recognized leader in cardiovascular imaging and women’s heart health, she serves on the editorial boards of the Journal of the American Society of Echocardiography, Circulation: Cardiovascular Imaging, and the imaging section of American College of Cardiology. She has led national efforts to improve echocardiographic quality and reporting standards through guideline development and implementation. Dr. Taub currently serves as President of the American Society of Echocardiography, where she is advancing a vision centered on scientific excellence, innovation, education, global collaboration, and the highest standards of cardiovascular ultrasound. She has won numerous teaching and mentorship awards, including the Richard Popp Excellence in Teaching Award by the American Society of Echocardiography. As a co-PI, she received the Joan and Douglas Zipes Publication of the Year Award in 2025 by the Heart Rhythm Society.
Guthrie Conference Faculty
![]() Hitesh Bhatia, MD | ![]() Umut Gomceli, MD, FACC, FASE, FASNC |
![]() Amber Hussain, DO, RPVI
| ![]() Resha Khanal, MD |
![]() Bikal Lamichhane, MD | ![]() Shahmeer Lodhi, MD |
![]() Ahmad Lone, MD | ![]() Shiavax Rao, MD |
![]() Hammad Rahman, MD
| ![]() Sudhakar Sattur, MD, MHSA |
![]() Saurabh Sharma, MD, FACC, FASE, FACP, RPVI | ![]() Daniel Sporn, MD, FACC, MHA |
![]() Prima Wulandari, MD |
|
| Have a question? Contact our staff! | |
|---|---|
![]() Trish Stern, Director, System CME | ![]() Laura Warner, CME Specialist |













